Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Integrated Concateno jumps into the black for H1

This article was originally published in Clinica

Executive Summary

Having completed integration of seven companies it acquired between 2006 and 2007, UK-based drugs-of-abuse testing company Concateno swung into pre-tax profit for the first half of this year. The UK-based firm recorded a pro forma loss of £1.2m a year earlier, but succeeded in pulling itself into the black with pre-tax profit of £0.7m for the first six months of 2008. Revenues during this period went up 14% to £23.3m ($41.8m), helped by particularly strong sales of its products in the workplace (+27%) and medico-legal (+32%) markets. The company said integration of the acquired businesses finished ahead of schedule, enabling it to book £0.8m of integration synergies in the first half. The annualised synergies – which is expected to be around £3m – will be realised in full by the fourth quarter of 2008. In addition to its H1 results, Concateno said that it was still mulling over a potential sale of the company, after being approached by several interested suitors in July (see Clinica No 1314, p 3), and will make a further announcement as appropriate.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042304

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel